The Shift in CIDP Treatment Toward Individualized, Evidence-Based Care: Karissa Gable, MD

The neurologist at Duke Health provided insights on how chronic demyelinating inflammatory polyneuropathy treatment is evolving toward biomarker-driven, personalized approaches at the 2025 Carolina Neuromuscular Summit. [WATCH TIME: 2 minutes]